AddLife AB (publ)

ST:ALIF-B Sweden Medical Instruments & Supplies
Market Cap
$1.45 Billion
Skr16.29 Billion SEK
Market Cap Rank
#6051 Global
#28 in Sweden
Share Price
Skr138.90
Change (1 day)
-0.29%
52-Week Range
Skr135.00 - Skr206.80
All Time High
Skr384.58
Categories
Companies in Sweden Medical Instruments & Supplies
About

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and labo… Read more

AddLife AB (publ) (ALIF-B) - Net Assets

Latest net assets as of December 2025: Skr5.45 Billion SEK

Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has net assets worth Skr5.45 Billion SEK as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr12.71 Billion) and total liabilities (Skr7.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr5.45 Billion
% of Total Assets 42.85%
Annual Growth Rate 25.2%
5-Year Change 26.94%
10-Year Change 659.8%
Growth Volatility 40.85

AddLife AB (publ) - Net Assets Trend (2012–2025)

This chart illustrates how AddLife AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for AddLife AB (publ) (2012–2025)

The table below shows the annual net assets of AddLife AB (publ) from 2012 to 2025.

Year Net Assets Change
2025-12-31 Skr5.45 Billion +2.60%
2024-12-31 Skr5.31 Billion +7.04%
2023-12-31 Skr4.96 Billion -0.22%
2022-12-31 Skr4.97 Billion +15.85%
2021-12-31 Skr4.29 Billion +127.00%
2020-12-31 Skr1.89 Billion +28.05%
2019-12-31 Skr1.48 Billion +58.44%
2018-12-31 Skr931.70 Million +24.56%
2017-12-31 Skr748.00 Million +4.34%
2016-12-31 Skr716.90 Million +106.84%
2015-12-31 Skr346.60 Million +31.64%
2014-12-31 Skr263.30 Million -3.06%
2013-12-31 Skr271.60 Million -7.40%
2012-12-31 Skr293.30 Million --

Equity Component Analysis

This analysis shows how different components contribute to AddLife AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Skr62.00 Million 1.14%
Other Components Skr5.38 Billion 98.86%
Total Equity Skr5.44 Billion 100.00%

AddLife AB (publ) Competitors by Market Cap

The table below lists competitors of AddLife AB (publ) ranked by their market capitalization.

Company Market Cap
Eternal Materials Co Ltd
TW:1717
 		$1.41 Billion
IBF Financial Holdings Co Ltd
TW:2889
 		$1.41 Billion
Cochin Shipyard Limited
NSE:COCHINSHIP
 		$1.41 Billion
Arcplus Group PLC
SHG:600629
 		$1.41 Billion
Sterling Check Corp
NASDAQ:STER
 		$1.41 Billion
American Superconductor Corporation
NASDAQ:AMSC
 		$1.41 Billion
Betta Pharmaceuticals Co Ltd
SHE:300558
 		$1.41 Billion
Huaxi Securities Co Ltd Class A
SHE:002926
 		$1.40 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in AddLife AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 5,306,000,000 to 5,443,000,000, a change of 137,000,000 (2.6%).
  • Net income of 560,000,000 contributed positively to equity growth.
  • Dividend payments of 91,000,000 reduced retained earnings.
  • Other comprehensive income decreased equity by 602,000,000.
  • Other factors increased equity by 270,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr560.00 Million +10.29%
Dividends Paid Skr91.00 Million -1.67%
Other Comprehensive Income Skr-602.00 Million -11.06%
Other Changes Skr270.00 Million +4.96%
Total Change Skr- 2.58%

Book Value vs Market Value Analysis

This analysis compares AddLife AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.11x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 43.34x to 3.11x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 Skr3.21 Skr138.90 x
2013-12-31 Skr2.97 Skr138.90 x
2014-12-31 Skr2.88 Skr138.90 x
2015-12-31 Skr4.40 Skr138.90 x
2016-12-31 Skr7.22 Skr138.90 x
2017-12-31 Skr7.31 Skr138.90 x
2018-12-31 Skr9.25 Skr138.90 x
2019-12-31 Skr13.18 Skr138.90 x
2020-12-31 Skr16.71 Skr138.90 x
2021-12-31 Skr35.72 Skr138.90 x
2022-12-31 Skr40.64 Skr138.90 x
2023-12-31 Skr40.69 Skr138.90 x
2024-12-31 Skr43.54 Skr138.90 x
2025-12-31 Skr44.66 Skr138.90 x

Capital Efficiency Dashboard

This dashboard shows how efficiently AddLife AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 10.29%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.36%
  • • Asset Turnover: 0.82x
  • • Equity Multiplier: 2.34x
  • Recent ROE (10.29%) is below the historical average (17.38%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 25.25% 8.14% 1.49x 2.08x Skr44.57 Million
2013 28.80% 7.93% 1.60x 2.26x Skr50.92 Million
2014 38.78% 5.92% 2.68x 2.45x Skr75.70 Million
2015 22.45% 4.98% 1.22x 3.68x Skr43.14 Million
2016 15.59% 5.77% 1.23x 2.20x Skr40.11 Million
2017 16.08% 5.16% 1.23x 2.53x Skr45.50 Million
2018 13.89% 5.21% 0.93x 2.87x Skr36.23 Million
2019 9.58% 4.04% 1.06x 2.23x Skr-6.09 Million
2020 27.51% 9.82% 1.27x 2.20x Skr329.59 Million
2021 16.78% 9.00% 0.75x 2.47x Skr290.48 Million
2022 9.66% 5.28% 0.70x 2.63x Skr-16.80 Million
2023 3.83% 1.96% 0.76x 2.57x Skr-305.80 Million
2024 4.75% 2.45% 0.79x 2.46x Skr-278.60 Million
2025 10.29% 5.36% 0.82x 2.34x Skr15.70 Million

Industry Comparison

This section compares AddLife AB (publ)'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $-31,439,925
  • Average return on equity (ROE) among peers: -26.72%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
AddLife AB (publ) (ALIF-B) Skr5.45 Billion 25.25% 1.33x $1.41 Billion
Biotage AB (BIOT) $476.77 Million 8.68% 0.24x $787.18 Million
Bonesupport Holding AB (BONEX) $124.31 Million -129.56% 0.58x $935.59 Million
Dynavox Group (DYVOX) $210.60 Million 23.08% 5.28x $777.82 Million
iZafe Group AB Series B (IZAFE-B) $9.04 Million -35.07% 0.67x $12.70 Million
Ortivus AB ser. A (ORTI-A) $84.63 Million -21.84% 0.94x $1.20 Million
S2Medical AB (S2M) $25.11 Million -73.41% 0.22x $641.00K
Stille AB (STIL) $189.81 Million 14.40% 0.80x $84.28 Million
Synsam AB (SYNSAM) $-1.37 Billion 0.00% 0.00x $726.29 Million